Early life acetaminophen exposure, glutathione S-transferase genes, and development of adolescent asthma in a high-risk birth cohort.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
11 2020
Historique:
received: 14 08 2019
revised: 27 03 2020
accepted: 31 03 2020
pubmed: 15 4 2020
medline: 16 3 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

Although the impact of early life acetaminophen on asthma risk is still not clear, potential interactions with glutathione S-transferase (GST) genes due to reduced antioxidant function in particular polymorphisms, and possible impact on lung function, have never been investigated in adolescents. We aimed to investigate associations between early life acetaminophen use and adolescent asthma and lung function and to assess potential interactions by GST polymorphisms. Acetaminophen use was recorded 18 times up to age 2 years (n = 575 [92.7%]). Participants were genotyped for GST polymorphisms (GSTM1/T1/P1) (n = 429 [69.2%]). Asthma and lung function were measured at 12 (n = 365 [58.9%]) and 18 years (n = 413 [66.6%]). Regression models assessed associations and interactions. Doubling of days of acetaminophen use was associated with reduced prebronchodilator FEV These novel findings need to be investigated for consistency in other studies but suggest that children carrying risk genotypes may be susceptible to respiratory consequences from acetaminophen use.

Sections du résumé

BACKGROUND
Although the impact of early life acetaminophen on asthma risk is still not clear, potential interactions with glutathione S-transferase (GST) genes due to reduced antioxidant function in particular polymorphisms, and possible impact on lung function, have never been investigated in adolescents.
OBJECTIVE
We aimed to investigate associations between early life acetaminophen use and adolescent asthma and lung function and to assess potential interactions by GST polymorphisms.
METHODS
Acetaminophen use was recorded 18 times up to age 2 years (n = 575 [92.7%]). Participants were genotyped for GST polymorphisms (GSTM1/T1/P1) (n = 429 [69.2%]). Asthma and lung function were measured at 12 (n = 365 [58.9%]) and 18 years (n = 413 [66.6%]). Regression models assessed associations and interactions.
RESULTS
Doubling of days of acetaminophen use was associated with reduced prebronchodilator FEV
CONCLUSIONS
These novel findings need to be investigated for consistency in other studies but suggest that children carrying risk genotypes may be susceptible to respiratory consequences from acetaminophen use.

Identifiants

pubmed: 32289338
pii: S0091-6749(20)30434-6
doi: 10.1016/j.jaci.2020.03.027
pii:
doi:

Substances chimiques

Biomarkers 0
Acetaminophen 362O9ITL9D
Glutathione Transferase EC 2.5.1.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035-1044.e12

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Xin Dai (X)

Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Australia.

Shyamali C Dharmage (SC)

Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Australia; Centre for Food and Allergy Research, Murdoch Children's Research Institute, Melbourne, Australia. Electronic address: S.dharmage@unimelb.edu.au.

Michael J Abramson (MJ)

School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia.

Bircan Erbas (B)

School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Catherine M Bennett (CM)

Institute for Health Transformation, Deakin University, Melbourne, Australia.

Cecilie Svanes (C)

Centre for International Health, University of Bergen, Bergen, Norway; Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Jennie Hui (J)

Pathwest Laboratory Medicine of West Australia, Perth, Australia; School of Population and Global Health and School of Pathology and Laboratory Medicine, the University of Western Australia, Crawley, Australia.

Christine Axelrad (C)

Centre for Food and Allergy Research, Murdoch Children's Research Institute, Melbourne, Australia.

Adrian J Lowe (AJ)

Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Australia; Centre for Food and Allergy Research, Murdoch Children's Research Institute, Melbourne, Australia.

Caroline J Lodge (CJ)

Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH